{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:19:46Z","timestamp":1793139586005,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:00:00Z","timestamp":1571270400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:00:00Z","timestamp":1571270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Medication Overuse Headache (MOH) is a prevalent and disabling disorder resulting from the overuse of analgesic drugs, triptans or other acute headache medications. In previous proteomic studies, several proteins have been found at high concentrations in the urine of MOH patients and in the serum of rats with neuropathic pain. The aim of this study was to compare the serum levels of lipocalin-type Prostaglandin D2 synthase (L-PGDS), Vitamin D-binding protein (VDBP), apolipoprotein E (APOE) and apolipoprotein A1 (APOA1) in MOH patients and healthy individuals, further exploring their relationship with cutaneous pain thresholds (CPTs) in the territories innervated by the trigeminal nerve.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Sixty-nine MOH patients and 42 age- and sex-matched healthy volunteers were enrolled in the study. Von Frey-like filaments were applied to the skin territories innervated by the trigeminal nerve, to determine the CPTs. L-PGDS, VDBP, APOE and APOA1 were quantified in the serum by Enzyme-linked Immunosorbent Assay (ELISA). Clinical and laboratory data were collected. Comparisons between MOH patients and healthy individuals were performed using independent t test or \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      test. To correlate serum proteins with CPTs, Pearson correlation coefficient or Spearman\u2019s rank correlation coefficient were used.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      CPTs were lower among MOH patients. L-PGDS, VDBP and APOE had significantly different serum concentrations between groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), but no correlation was found with CPTs. APOA1 serum concentrations did not differ between patients and healthy individuals.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>L-PGDS, VDBP and APOE had abnormal serum levels in MOH patients, confirming their alteration in some conditions of chronic headache and neuropathic pain. However, they had no relationship with CPTs. The in-depth study of serum proteins represents a promising approach for a better understanding of MOH, as well as the detection of candidate biomarkers for chronic headache or the risks associated with overuse medications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-019-1469-1","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T09:10:08Z","timestamp":1571303408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication\u2013overuse headache"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4137-5039","authenticated-orcid":false,"given":"Lanfranco","family":"Pellesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Bellei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Guerzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Michela","family":"Cainazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Baraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Monari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi Alberto","family":"Pini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,17]]},"reference":[{"key":"1469_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/bja\/aet123","volume":"111","author":"O van Hecke","year":"2013","unstructured":"van Hecke O, Torrance N, Smith BH. Chronic pain epidemiology and its clinical relevance. Br J Anaesth. 2013;111:13\u20138.","journal-title":"Br J Anaesth"},{"key":"1469_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jpain.2012.03.009","volume":"13","author":"DJ Gaskin","year":"2012","unstructured":"Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain. 2012;13:715\u201324.","journal-title":"J Pain"},{"key":"1469_CR3","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/nm1208-1313","volume":"14","author":"CJ Pallen","year":"2008","unstructured":"Pallen CJ. Breaking the pain connection. Nat Med. 2008;14:1313\u20135.","journal-title":"Nat Med"},{"key":"1469_CR4","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","volume":"153","author":"CJ Woolf","year":"2011","unstructured":"Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;153:S2\u2013S15.","journal-title":"Pain"},{"key":"1469_CR5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","volume":"10","author":"A Latremoliere","year":"2009","unstructured":"Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10:895\u2013926.","journal-title":"J Pain"},{"key":"1469_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1468-1331.2006.01184.x","volume":"13","author":"LJ Stovner","year":"2006","unstructured":"Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J. Epidemiology of headache in Europe. Eur J Neurol. 2006;13:333\u201345.","journal-title":"Eur J Neurol"},{"key":"1469_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1586\/14737167.4.3.353","volume":"4","author":"R Jensen","year":"2004","unstructured":"Jensen R, Rasmussen BK. Burden of headache. Expert Rev Pharmacoecon Outcomes Res. 2004;4:353\u20139.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"1469_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Headache Classification Committee of the International Headache Society","year":"2013","unstructured":"Headache Classification Committee of the International Headache Society. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629\u2013808.","journal-title":"Cephalalgia"},{"key":"1469_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1046\/j.1526-4610.2003.03041.x","volume":"43","author":"A Bahra","year":"2003","unstructured":"Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache. 2003;43:179\u201390.","journal-title":"Headache"},{"key":"1469_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1046\/j.1526-4610.2001.111006303.x","volume":"41","author":"SM Wilkinson","year":"2001","unstructured":"Wilkinson SM, Becker WJ, Heine JA. Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache. 2001;41:303\u20139.","journal-title":"Headache"},{"key":"1469_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/WCO.0b013e328346af25","volume":"24","author":"M De Felice","year":"2011","unstructured":"De Felice M, Ossipov MH, Porreca F. Persistent medication-induced neural adaptations, descending facilitation, and medication overuse headache. Curr Opin Neurol. 2011;24:193\u20136.","journal-title":"Curr Opin Neurol"},{"key":"1469_CR12","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1212\/01.wnl.0000310645.31020.b1","volume":"70","author":"ME Bigal","year":"2008","unstructured":"Bigal ME, Ashina S, Burstein R, Reed ML, Buse D, Serrano D, Lipton RB, AMPP group. Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology. 2008;70:1525\u201333.","journal-title":"Neurology"},{"key":"1469_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1129-2377-14-6","volume":"14","author":"E Bellei","year":"2013","unstructured":"Bellei E, Monari E, Cuoghi A, Bergamini S, Guerzoni S, Ciccarese M, Ozben T, Tomasi A, Pini LA. Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache. J Headache Pain. 2013;14:6.","journal-title":"J Headache Pain"},{"key":"1469_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s10194-015-0559-8","volume":"16","author":"E Bellei","year":"2015","unstructured":"Bellei E, Monari E, Bergamini S, Cuoghi A, Tomasi A, Guerzoni S, Ciccarese M, Pini LA. Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache. J Headache Pain. 2015;16:77.","journal-title":"J Headache Pain"},{"key":"1469_CR15","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/0024-3205(82)90101-1","volume":"31","author":"S Narumiya","year":"1982","unstructured":"Narumiya S, Ogorochi T, Nakao K, Hayaishi O. Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution. Life Sci. 1982;31:2093\u2013103.","journal-title":"Life Sci"},{"key":"1469_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0952-3278(89)90033-1","volume":"37","author":"S Ito","year":"1989","unstructured":"Ito S, Narumiya S, Hayaishi O. Prostaglandin D2: a biochemical perspective. Prostaglandins Leukotrienes Essent Fatty Acids. 1989;37:219\u201334.","journal-title":"Prostaglandins Leukotrienes Essent Fatty Acids"},{"key":"1469_CR17","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1096\/fasebj.5.11.1907936","volume":"5","author":"O Hayaishi","year":"1991","unstructured":"Hayaishi O. Molecular mechanisms of sleep-wake regulation: roles of prostaglandins D2 and E. FASEB J. 1991;5:2575\u201381.","journal-title":"FASEB J"},{"key":"1469_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0929-7855(96)01511-8","volume":"14","author":"Y Urade","year":"1996","unstructured":"Urade Y, Hayaishi O, Matsumura H, Watanabe K. Molecular mechanism of sleep regulation by prostaglandin D2. J Lipid Mediat Cell Signal. 1996;14:71\u201382.","journal-title":"J Lipid Mediat Cell Signal"},{"key":"1469_CR19","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1073\/pnas.96.2.726","volume":"96","author":"N Eguchi","year":"1999","unstructured":"Eguchi N, Minami T, Shirafuji N, Kanaoka Y, Tanaka T, Nagata A, Yoshida N, Urade Y, Ito S, Hayaishi O. Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. Proc Natl Acad Sci U S A. 1999;96:726\u201330.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1469_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0168-0102(01)00289-9","volume":"41","author":"S Ito","year":"2001","unstructured":"Ito S, Okuda-Ashitaka E, Minami T. Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin. Neurosci Res. 2001;41:299\u2013332.","journal-title":"Neurosci Res"},{"key":"1469_CR21","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1248\/bpb.34.1170","volume":"34","author":"A Kawabata","year":"2011","unstructured":"Kawabata A. Prostaglandin E2 and pain \u2013 an update. Biol Pharm Bull. 2011;34:1170\u20133.","journal-title":"Biol Pharm Bull"},{"key":"1469_CR22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.pain.2008.03.018","volume":"139","author":"T Wienecke","year":"2008","unstructured":"Wienecke T, Olesen J, Oturai PS, Ashina M. Prostacyclin (epoprostenol) induces headache in healthy subject. Pain. 2008;139:106\u201316.","journal-title":"Pain"},{"key":"1469_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1468-2982.2008.01748.x","volume":"29","author":"T Wienecke","year":"2009","unstructured":"Wienecke T, Olesen J, Oturai PS, Ashina M. Prostaglandin E2 (PGE2) induces headache in healthy subjects. Cephalalgia. 2009;29:509\u201319.","journal-title":"Cephalalgia"},{"key":"1469_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1468-2982.2009.01923.x","volume":"30","author":"T Wienecke","year":"2010","unstructured":"Wienecke T, Olesen J, Ashina M. Prostaglandin I2 (epoprostenol) triggers migraine like attacks in migraineurs. Cephalalgia. 2010;30:179\u201390.","journal-title":"Cephalalgia"},{"key":"1469_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1177\/0333102410373156","volume":"31","author":"T Wienecke","year":"2011","unstructured":"Wienecke T, Olesen J, Ashina M. Discrepancy between strong cephalic arterial dilatation and mild headache caused by prostaglandin D2 (PGD2). Cephalalgia. 2011;31:65\u201376.","journal-title":"Cephalalgia"},{"key":"1469_CR26","doi-asserted-by":"publisher","first-page":"41723","DOI":"10.1038\/srep41723","volume":"7","author":"E Bellei","year":"2017","unstructured":"Bellei E, Vilella A, Monari E, Bergamini S, Tomasi A, Cuoghi A, Guerzoni S, Manca L, Zoli M, Pini LA. Serum protein changes in a rat model of chronic pain show a correlation between animal and humans. Sci Rep. 2017;7:41723.","journal-title":"Sci Rep"},{"key":"1469_CR27","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1468-2982.2008.01819.x","volume":"29","author":"ME Bigal","year":"2009","unstructured":"Bigal ME, Borucho S, Serrano D, Lipton RB. The acute treatment of episodic and chronic migraine in the USA. Cephalalgia. 2009;29:891\u20137.","journal-title":"Cephalalgia"},{"key":"1469_CR28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10194-011-0313-9","volume":"12","author":"M Zappaterra","year":"2011","unstructured":"Zappaterra M, Guerzoni S, Cainazzo MM, Ferrari A, Pini LA. Basal cutaneous pain threshold in headache patients. J Headache Pain. 2011;12:303\u201310.","journal-title":"J Headache Pain"},{"key":"1469_CR29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1526-4610.2005.05111.x","volume":"45","author":"M Peters","year":"2005","unstructured":"Peters M, Abu-Saad HH, Robbins I, Vydelingum V, Dowson A, Murphy M. Patients' management of migraine and chronic daily headache: a study of the members of the migraine action association (United Kingdom). Headache. 2005;45:571\u201381.","journal-title":"Headache"},{"key":"1469_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pharep.2016.09.015","volume":"69","author":"A Sekeroglu","year":"2017","unstructured":"Sekeroglu A, Jacobsen JM, Jansen-Olesen I, Gupta S, Sheykhzade M, Olesen J, Bhatt DK. Effect of PGD2 on middle meningeal artery and mRNA expression profile of L-PGD2 synthase and DP receptors in trigeminovascular system and other pain processing structures in rat brain. Pharmacol Rep. 2017;69:50\u20136.","journal-title":"Pharmacol Rep"},{"key":"1469_CR31","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/sj.bjp.0704357","volume":"134","author":"DW Jenkins","year":"2001","unstructured":"Jenkins DW, Feniuk W, Humphrey PPA. Characterization of the prostanoid receptor types involved in mediating calcitonin gene-related peptide release from cultured rat trigeminal neurones. Br J Pharmacol. 2001;134:1296\u2013302.","journal-title":"Br J Pharmacol"},{"key":"1469_CR32","first-page":"229","volume":"3","author":"MG Harrington","year":"1993","unstructured":"Harrington MG, Aebersold R, Martin BM, Merril CR, Hood L. Identification of a brain-specific human cerebrospinal fluid glycoprotein, beta-trace protein. Appl Theor Electrophor. 1993;3:229\u201334.","journal-title":"Appl Theor Electrophor"},{"key":"1469_CR33","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1248\/bpb.16.949","volume":"16","author":"A Hiraoka","year":"1993","unstructured":"Hiraoka A, Miura I, Hattori M, Tominaga L, Machida S. Capillary-zone electrophoretic analyses of the proteins and amino acid components in cerebrospinal fluid of central nervous system diseases. Biol Pharm Bull. 1993;16:949\u201352.","journal-title":"Biol Pharm Bull"},{"key":"1469_CR34","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1053\/j.ajkd.2004.12.005","volume":"45","author":"C Huerta","year":"2005","unstructured":"Huerta C, Castellsague J, Varas-Lorenzo C, Garc\u00eda Rodr\u00edguez LA. Nonsteroidal anti-inflammatory drugs and risk for ARF in the general population. Am J Kidney Dis. 2005;45:531\u20139.","journal-title":"Am J Kidney Dis"},{"key":"1469_CR35","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.ekir.2018.05.003","volume":"3","author":"B Abramovitz","year":"2018","unstructured":"Abramovitz B, Leonberg-Yoo A, Bahrainwala JZ, Litt H, Rudnick MR. Bilateral renal infarctions during the use of sumatriptan. Kidney Int Rep. 2018;3:1233\u20136.","journal-title":"Kidney Int Rep"},{"key":"1469_CR36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/glycob\/7.4.499","volume":"7","author":"A Hoffmann","year":"1997","unstructured":"Hoffmann A, Nimtz M, Conradt HS. Molecular characterization of \u03b2-trace protein in human serum and urine: a potential diagnostic marker for renal diseases. Glycobiology. 1997;7:499\u2013506.","journal-title":"Glycobiology"},{"key":"1469_CR37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1053\/snep.2002.34726","volume":"22","author":"JK Maesaka","year":"2002","unstructured":"Maesaka JK, Palaia T, Fishbane S, Ragolia L. Contribution of prostaglandin D2 synthase to progression of renal failure and dialysis dementia. Semin Nephrol. 2002;22:407\u201314.","journal-title":"Semin Nephrol"},{"key":"1469_CR38","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/S0021-9258(19)85885-4","volume":"255","author":"H Van Baelen","year":"1980","unstructured":"Van Baelen H, Bouillon R, De Moor P. Vitamin D-binding protein (Gc-globulin) binds actin. J Biol Chem. 1980;255:2270\u20132.","journal-title":"J Biol Chem"},{"key":"1469_CR39","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.4049\/jimmunol.151.5.2794","volume":"151","author":"N Yamamoto","year":"1993","unstructured":"Yamamoto N, Kumashiro R. Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells. J Immunol. 1993;151:2794\u2013802.","journal-title":"J Immunol"},{"key":"1469_CR40","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3109\/03008207.2012.746320","volume":"54","author":"YM Oh","year":"2013","unstructured":"Oh YM, Ma TZ, Kwak YG, Eun JP. Proteomic evaluation to identify biomarkers for carpal tunnel syndrome: a comparative serum analysis. Connect Tissue Res. 2013;54:76\u201381.","journal-title":"Connect Tissue Res"},{"key":"1469_CR41","doi-asserted-by":"publisher","first-page":"e105319","DOI":"10.1371\/journal.pone.0105319","volume":"9","author":"E Nagata","year":"2014","unstructured":"Nagata E, Fujii N, Hosomichi K, Mitsunaga S, Suzuki Y, Mashimo Y, Tsukamoto H, Satoh T, Osawa M, Inoue I, Hata A, Takizawa S. Possible association between dysfunction of vitamin D binding protein (GC globulin) and migraine attacks. PLoS One. 2014;9:e105319.","journal-title":"PLoS One"},{"key":"1469_CR42","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1468-2982.2008.01727.x","volume":"29","author":"SH B\u00f8","year":"2009","unstructured":"B\u00f8 SH, Davidsen EM, Gulbrandsen P, Dietrichs E, Bovim G, Stovner LJ, White LR. Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia. 2009;29:365\u201372.","journal-title":"Cephalalgia"},{"key":"1469_CR43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/jnr.20612","volume":"82","author":"X Qin","year":"2005","unstructured":"Qin X, Wan Y, Wang X. CCL2 and CXCL1 trigger calcitonin gene-related peptide release by exciting primary nociceptive neurons. J Neurosci Res. 2005;82:51\u201362.","journal-title":"J Neurosci Res"},{"key":"1469_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s40122-015-0036-8","volume":"4","author":"EE Shipton","year":"2015","unstructured":"Shipton EE, Shipton EA. Vitamin D deficiency and pain: clinical evidence of low levels of vitamin D and supplementation in chronic pain states. Pain Ther. 2015;4:67\u201387.","journal-title":"Pain Ther"},{"key":"1469_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5539\/gjhs.v5n5p102","volume":"5","author":"M Abbasi","year":"2013","unstructured":"Abbasi M, Hashemipour S, Hajmanuchehri F, Kazemifar M. Is vitamin D deficiency associated with non specific musculoskeletal pain? Glob Health J Sci. 2013;5:107\u201311.","journal-title":"Glob Health J Sci"},{"key":"1469_CR46","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/j.1526-4637.2008.00415.x","volume":"9","author":"MK Turner","year":"2008","unstructured":"Turner MK, Hooten WM, Schmidt JE, Kerkvliet JL, Townsend CO, Bruce BK. Prevalence and clinical correlates of vitamin D inadequacy among patients with chronic pain. Pain Med. 2008;9:979\u201384.","journal-title":"Pain Med"},{"key":"1469_CR47","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1111\/ijcp.12456","volume":"68","author":"A Celikbilek","year":"2014","unstructured":"Celikbilek A, Gocmen AY, Zararsiz G, Tanik N, Ak H, Borekci E, Delibas N. Serum levels of vitamin D, vitamin D-binding protein and vitamin D receptor in migraine patients from Central Anatolia region. Int J Clin Pract. 2014;68:1272\u20137.","journal-title":"Int J Clin Pract"},{"key":"1469_CR48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.mehy.2018.02.033","volume":"114","author":"H Dhillon","year":"2018","unstructured":"Dhillon H, Singh S. Role of apolipoprotein E in the tangled mystery of pain. Med Hypotheses. 2018;114:58\u201364.","journal-title":"Med Hypotheses"},{"key":"1469_CR49","first-page":"14","volume":"9","author":"OK Melemedjian","year":"2013","unstructured":"Melemedjian OK, Yassine HN, Shy A, Price TJ. Proteomic and functional annotation analysis of injured peripheral nerves reveal ApoE as a protein upregulated by injury that is modulated by metformin treatment. Mol Pain. 2013;9:14.","journal-title":"Mol Pain"},{"key":"1469_CR50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10194-008-0094-y","volume":"10","author":"R Gupta","year":"2009","unstructured":"Gupta R, Kumar V, Luthra K, Banerjee B, Bathia MS. Polymorphism in apolipoprotein E among migraineurs and tension-type headache subjects. J Headache Pain. 2009;10:115\u201320.","journal-title":"J Headache Pain"},{"key":"1469_CR51","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12883-015-0385-2","volume":"15","author":"J Miao","year":"2015","unstructured":"Miao J, Wang F, Zheng W, Zhuang X. Association of the Apolipoprotein E polymorphism with migraine: a meta-analysis. BMC Neurol. 2015;15:138.","journal-title":"BMC Neurol"},{"key":"1469_CR52","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrneurol.2016.124","volume":"12","author":"HC Diener","year":"2016","unstructured":"Diener HC, Holle D, Solbach K, Gaul C. Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol. 2016;12:575\u201383.","journal-title":"Nat Rev Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1469-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-019-1469-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1469-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T16:00:03Z","timestamp":1695312003000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-019-1469-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,17]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1469"],"URL":"https:\/\/doi.org\/10.1186\/s12883-019-1469-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.9106\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.9106\/v2","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,17]]},"assertion":[{"value":"22 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed following the Helsinki Declaration principles, approved by the local Ethical Committee of Modena (prot. 2073) and subsequently amended by the Area Vasta Emilia Nord Ethics Committee (prot. 0019446\/18). All patients and healthy volunteers gave their written consent to participate in the study before any experimental procedure was performed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"239"}}